| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.09. | LevelJump Healthcare Corp.: LevelJump Announces Management Change | 414 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") wishes to announce the appointment of Gus Patel as the Company's interim... ► Artikel lesen | |
| 25.08. | LevelJump Healthcare Corp.: LevelJump Announces Q2 Record Revenue | 534 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the second quarter... ► Artikel lesen | |
| LEVELJUMP HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 18.07. | Leveljump Healthcare Corp: Leveljump CTO revoked; shares to be reinstated | 2 | Stockwatch | ||
| 18.07. | LevelJump Healthcare Corp.: LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading on TSX Venture Exchange | 1.360 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of April 30,... ► Artikel lesen | |
| 15.07. | Leveljump Healthcare reports FY results | 3 | Seeking Alpha | ||
| 15.07. | LevelJump Healthcare Corp.: LevelJump Announces 2026 Q1 Financial Results | 573 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March... ► Artikel lesen | |
| 15.07. | LevelJump Healthcare Corp.: LevelJump Announces 2025 Financial Results | 592 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December... ► Artikel lesen | |
| 13.05. | Leveljump Healthcare Corp: Leveljump 14.38-million-share private placement | 1 | Stockwatch | ||
| 07.05. | XFRA 75J: AUSSETZUNG/SUSPENSION | 218 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLEVELJUMP HEALTHCARE... ► Artikel lesen | |
| 30.04. | LevelJump Healthcare Corp.: LevelJump Announces Delay in Filing Annual Financial Statements | 417 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services... ► Artikel lesen | |
| 20.04. | LevelJump Healthcare Corp.: LevelJump Closes Non-Brokered Private Placement | 444 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce that, further to its news release of April 7... ► Artikel lesen | |
| 08.04. | LevelJump Healthcare Corp.: LevelJump Announces Non-Brokered Private Placement | 585 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services,... ► Artikel lesen | |
| 26.02. | LevelJump Healthcare Corp.: LevelJump Announces Grant of Stock Options | 255 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant to the Company's 2022 Equity Incentive Plan... ► Artikel lesen | |
| 20.01. | LevelJump Healthcare Corp.: LevelJump Enters into Cooperation Agreement with Concerned Shareholder; Announces Board Reconstitution | 801 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic... ► Artikel lesen | |
| 20.11.25 | LevelJump Healthcare Corp.: LevelJump Sets Date for Requisitioned Shareholder Meeting | 535 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 20, 2025) - Further to its news release of November 7, 2025, LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces that its board... ► Artikel lesen | |
| 11.11.25 | LevelJump Healthcare Corp.: LevelJump Announces 2025 Third Quarter Results | 542 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months and... ► Artikel lesen | |
| 07.11.25 | LevelJump Healthcare Corp.: LevelJump Announces Receipt of Notice of Requisition for a Meeting of Shareholders | 888 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 7, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces that a notice of requisition of a meeting of shareholders (the... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | -2,58 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,97 | +0,12 % | BrightSpring projects at least $700M 2026 operating cash flow while reiterating 15%-20% 2027 organic adjusted EBITDA growth | ||
| FRESENIUS | 47,795 | +1,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,280 | +0,14 % | Alignment Healthcare lowers 2026 outlook as it navigates cost headwinds | ||
| HEARTFLOW | 59,11 | +0,10 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| GERRESHEIMER | 32,040 | +0,44 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer mit einem Kursziel von 46 Euro auf "Overweight" belassen. David Adlington passte sein Bewertungsmodell für den Verpackungsspezialisten... ► Artikel lesen | |
| GENEDX | 69,04 | -0,03 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CARL ZEISS MEDITEC | 34,980 | +0,63 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| LIFESTANCE HEALTH GROUP | 13,410 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 29,210 | +0,07 % | Progyny's (PGNY) Full-Year Guidance Lowered on Utilization Headwinds | ||
| BETA BIONICS | 16,730 | -0,12 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| BILLIONTOONE | 113,21 | -0,10 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| DRAEGERWERK | 102,00 | -3,23 % | EQS-DD: Drägerwerk AG & Co. KGaA: Dr. Heinrich Dräger GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.10.2026 / 11:57... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,490 | +0,05 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |